Janine Senz
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Interpreting homologous recombination deficiency in rare gynecological cancers: A case of primary mucinous endometrial adenocarcinoma of gastrointestinal type.
Journal: Gynecologic oncology reports
Published: June 23, 2026
Proficiency Testing of p53 Immunohistochemistry Pattern Read-out in Vulvar Biopsies Demonstrates Frequent Basal Overexpression Interpretation in TP53 Wild-type Cases.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: May 15, 2025
Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities.
Journal: NPJ precision oncology
Published: April 26, 2025
Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 06, 2025
CDKN2A Chromogenic In Situ Hybridization for Separating Benign From Malignant Mesothelial Proliferations.
Journal: The American journal of surgical pathology
Published: March 31, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.
Journal: The Journal of pathology
Published: January 26, 2025
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.
Journal: Nature communications
Published: February 26, 2024
The unique metabolome of clear cell ovarian carcinoma.
Journal: The Journal of pathology
Published: February 25, 2024
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.
Journal: Journal of gynecologic oncology
Published: February 08, 2024
Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 24, 2023
Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 14, 2023
Last Updated: 09/26/2026